Tango Therapeutics director awarded RSUs and options
Tango Therapeutics director John B. Ketchum received an equity grant consisting of 4,000 restricted stock units and an option for 25,000 shares of Common Stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tango Therapeutics director John B. Ketchum received an equity grant consisting of 4,000 restricted stock units and an option for 25,000 shares of Common Stock. The RSUs vest in full on the earlier of June 5, 2027 or the next annual stockholder meeting, subject to continued service. The stock option, with a $20.22 exercise price, vests in 12 equal monthly installments beginning July 5, 2026 and expires on June 5, 2036. Following these grants, Ketchum directly holds 24,937 shares of Common Stock.
Insider Trade Summary
Grant/Award: 29,000 shares
Grant/Award
2 txns
Insider
Ketchum John B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 4,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 contracts (Direct);
Common Stock — 24,937 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- F2. This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
RSU grant: 4,000 shares
Stock option grant size: 25,000 shares
Option exercise price: $20.22/share
+3 more
6 metrics
RSU grant
4,000 shares
Restricted stock units granted to director on June 5, 2026
Stock option grant size
25,000 shares
Option covering Common Stock granted on June 5, 2026
Option exercise price
$20.22/share
Exercise price for 25,000-share stock option
Option expiration
June 5, 2036
Expiration date of stock option grant
Vesting start for option
July 5, 2026
First monthly vesting date for the stock option
Shares held after grant
24,937 shares
Non-derivative Common Stock directly held after transactions
Key Terms
restricted stock units, RSUs, Stock Option (Right to Buy), vest, +1 more
5 terms
restricted stock units financial
"These shares are represented by restricted stock units (the "RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of Common Stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)" for 25,000.0000 shares."
vest financial
"The RSUs will vest in their entirety on the earlier of June 5, 2027 or the next annual meeting."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price: "20.2200" for the stock option grant."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Tango Therapeutics (TNGX) director John B. Ketchum receive in this Form 4 filing?
John B. Ketchum received equity compensation, including 4,000 restricted stock units and a stock option for 25,000 shares. These awards are part of his compensation as a director and are subject to multi-year vesting and service-based conditions.
How do the 4,000 restricted stock units for TNGX director Ketchum vest?
The 4,000 RSUs vest in full on the earlier of June 5, 2027 or the date of the next annual stockholder meeting. Vesting is contingent on Ketchum’s continuous service with Tango Therapeutics through the applicable vesting date.
Are Ketchum’s Tango Therapeutics (TNGX) equity awards open-market purchases or compensation grants?
The reported transactions are compensation-related grants, not open-market purchases. Both the 4,000 RSUs and the 25,000-share stock option were awarded at a $0.00 grant price under a grant or award code, subject to vesting and service conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates